TNDMTandem Diabetes Care, Inc.
$16.12+28% 1Y
$16.12
$11.7952 weeks$28.26
TNDM in its own filings
TNDM's filing record carries one kind of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
266
Events found in the filings · across 1,259 filings · the record starts in 2013
- Hard flags
- 1
Hard flags
- Most recent filing
- Aug 6, 2026
Most recent filing · Form 10-Q
- Record starts
- Sep 6, 2013
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 5, 2026
- Delisting notice / listing-rule failurehistorical
- 2017-06-16
- SEC comment-letter activity30 occurrences
- 2025-06-26
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 6, 2026Tandem Diabetes Care Announces Second Quarter 2026 Financial Results.Earnings release · press release
- May 21, 2026At the Annual Meeting, the Company’s stockholders also approved the Company’s 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares of the Company’s common stock (Common Stock) authorized for issuance under the plan by 3,260,000 shares (as so amended, the Amended Plan)Shareholder rights modified · Form 8-K
- May 15, 2026On May 11, 2026, Mark Novara, the Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc. (the “Company”), was notified that his employment with the Company is being terminated without cause.Director or officer change · Form 8-K
- May 7, 2026Tandem Diabetes Care Announces First Quarter 2026 Financial Results.Earnings release · press release
- Feb 27, 2026Entry into a Material Agreement.Material agreement entered · Form 8-K
- Feb 19, 2026Tandem Diabetes Care Announces Fourth Quarter and Full Year 2025 Financial Results.Earnings release · press release
- Dec 30, 2025On December 26, 2025, in connection with a standard periodic review of the governance documents of Tandem Diabetes Care, Inc. (the “Company”), the Company’s board of directors (the “Board”) adopted Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), which became effective immediately and …Charter/bylaw amendment or fiscal-year change · Form 8-K
- Nov 12, 2025Appointment of Sandra Beaver as Director On November 7, 2025, the Board of Directors (the “Board”) of Tandem Diabetes Care, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, increased the size of the Board from eight to nine directors and appointed Sandra …Director or officer change · Form 8-K
- Nov 6, 2025Tandem Diabetes Care Announces Third Quarter 2025 Financial Results.Earnings release · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
On our screens:Most shorted stocks